openPR Logo
Press release

Peripheral Neuropathy Treatment Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

09-25-2023 11:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Peripheral Neuropathy Treatment Market Share, Trends, Future

The global peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.3% during the forecast period. A significant rise in diabetes prevalence is the major factor in accelerating market growth. As per the International Diabetes Federation (IDF), in 2019, nearly 463 million adults (20-79 years) were suffering from diabetes, which is expected to reach 700 million by 2045. Uncontrolled high blood sugar can damage nerves and impede nerves' ability to transmit signals, which results in diabetic neuropathy. High blood sugar also impairs the walls of the capillaries (small blood vessels) that deliver the nerves with nutrients and oxygen. Peripheral neuropathy is a common type of diabetic neuropathy, which firstly affects the legs and feet, followed by the arms and hands.

A full report of Peripheral Neuropathy Treatment Market is available at: https://www.omrglobal.com/industry-reports/peripheral-neuropathy-treatment-market

It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This, in turn, is contributing to the demand for peripheral neuropathy treatment. The most commonly used drugs for the condition include anti-seizure drugs, antidepressants, and pain-relievers. Anti-seizure medications include pregabalin (Lyrica) and gabapentin (Gralise, Neurontin). Some antidepressants are used to ease nerve pain, even the patient is not depressed. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin), imipramine (Tofranil), and amitriptyline.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/peripheral-neuropathy-treatment-market

Scope of the Global Peripheral Neuropathy Treatment Market

Market Coverage

The market number available for 2019-2026
Base year- 2019
Forecast period- 2020-2026
Segment Covered- By Type and Application
Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
Competitive Landscape- Pfizer Inc., Grünenthal GmbH, Novartis International AG, Eli Lilly and Co., and Daiichi Sankyo Co. Ltd.

Recent Strategic Initiatives in the Global Peripheral Neuropathy Treatment Market

In July 2020, Grünenthal declared that its subsidiary Averitas Pharma, Inc. gained US FDA approval for QUTENZA (capsaicin) 8% patch to treat neuropathic pain related to diabetic peripheral neuropathy of the feet in adults. It is a topical, non-opioid pain, and non-systemic treatment that is delivered in the patch form. It is the first and only treatment of its kind that delivers prescription-strength capsaicin directly into the skin. The patch can offer sustained relief for up to three months. It has no known drug-drug interactions. Its adverse reactions comprise application site reactions, such as pruritus, erythema, and pain.

In July 2019, Rising Pharmaceuticals, Inc. declared the introduction of a generic version of Lyrica, (pregabalin) capsules in the US. These capsules are intended for neuropathic pain management related to diabetic peripheral neuropathy, for the management of fibromyalgia, and others.

Key questions addressed by the report

What is the market growth rate?
Which segment/region dominates the market in the base year?
Which segment/region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected region/segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Peripheral Neuropathy Treatment Market-Segmentation

By Type

Antidepressants
Pain Relievers
Antiseizure
Others

By Application

Diabetes
Chemotherapy-Induced
Others

Peripheral Neuropathy Treatment Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Achelios Therapeutics, Inc.
Acorda Therapeutics, Inc.
Alembic Pharmaceuticals, Ltd.
Amneal Pharmaceuticals LLC
Apotex, Inc.
Assertio Therapeutics, Inc.
Bristol Myers Squibb Co.
Cipla, Ltd.
Daiichi Sankyo Company, Ltd.
Eli Lilly and Co.
GlaxoSmithKline plc
Glenmark Pharmaceuticals, Ltd.
Grünenthal GmbH
Innovus Pharmaceuticals, Inc.
Johnson & Johnson Services, Inc.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral Neuropathy Treatment Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 here

News-ID: 3223214 • Views:

More Releases from Orion Market Research

Specular Hematite Market Is Booming Worldwide | Latest Study Reveal for the forecast to 2033
Specular Hematite Market Is Booming Worldwide | Latest Study Reveal for the fore …
The Specular Hematite Market was valued at USD 1.8 billion in 2023 and is expected to grow to approximately USD 3.08 billion by 2033, reflecting a CAGR of about 5.5% from 2024 to 2033. Specular Hematite Market Overview The Specular Hematite Market growth is driven by its increasing demand in various industrial applications, particularly in the sectors of construction and automotive, where Specular Hematite is used extensively due to its unique properties.
Compressed Natural Gas (CNG) Truck Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Compressed Natural Gas (CNG) Truck Market Size Analysis, Competitive Insights, L …
The global CNG heavy‐duty truck market was approximately USD 8.5 billion, and by 2033 it is expected to reach around USD 15.2 billion, reflecting a CAGR of 6.0% over the period from 2024 to 2033. Compressed Natural Gas (CNG) Truck Market Overview The CNG truck market-especially in heavy duty applications-is experiencing steady growth, underpinned by increasing environmental regulations and the push towards cleaner transportation. Heavy duty CNG trucks are gaining traction due
Artificial Intelligence (AI) in Precision Medicine Market Rising Demand and Growth Forecast Through 2033
Artificial Intelligence (AI) in Precision Medicine Market Rising Demand and Grow …
In 2023, the global AI in Precision Medicine market was approximately USD 1.73 billion, and by 2033 it is projected to reach around USD 37.01 billion, reflecting a compound annual growth rate (CAGR) of 35.84% from 2024 to 2033. Artificial Intelligence (AI) in Precision Medicine Market Overview The AI in Precision Medicine market is experiencing explosive growth, driven by breakthroughs in deep learning, natural language processing, and context aware computing that enable
Artificial Intelligence (AI) in Medical Writing Market : A Guide to Understanding the Process
Artificial Intelligence (AI) in Medical Writing Market : A Guide to Understandin …
In 2023, the global AI in Medical Writing market was approximately USD 799.2 million, and by 2033 it is expected to reach about USD 2,598.7 million, representing a CAGR of 12.8% from 2024 to 2033. Artificial Intelligence (AI) in Medical Writing Market Overview The AI in Medical Writing market is witnessing strong growth, driven by the need to streamline and enhance the accuracy of critical documents such as clinical study reports, regulatory

All 5 Releases


More Releases for Peripheral

Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev …
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820 This latest report researches the industry structure,
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a